| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 25,685 | 44,213 | 28,608 | 29,740 | | Cost of Revenue | 19,038 | 33,367 | 20,771 | 22,418 | | | Gross Profit | 6,647 | 10,846 | 7,837 | 7,322 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,362 | 8,505 | 9,424 | 7,946 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,627 | 1,858 | 1,625 | 1,459 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,342) | 483 | (3,212) | (2,083) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 115 | 163 | 253 | 192 | | Earnings Before Interest And Taxes | (1,227) | 646 | (2,959) | (1,891) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,227) | 646 | (2,959) | (1,891) | | Income Tax Expense | 38 | 1 |
-
| 1 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,265) | 645 | (2,959) | (1,892) | | | Non-recurring Events | | Discontinued Operations | 37 | (408) | (2,402) | (3,262) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,228) | 237 | (5,361) | (5,154) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,228) | $237 | ($5,361) | ($5,154) |
|
0.51% Nasdaq 
Income Statement
